Share on StockTwits

Fibrocell Science (NASDAQ:FCSC) posted its quarterly earnings results on Monday. The company reported ($0.35) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.15) by $0.20, American Banking and Market News reports.

Shares of Fibrocell Science (NASDAQ:FCSC) traded down 2.58% on Monday, hitting $3.02. 70,240 shares of the company’s stock traded hands. Fibrocell Science has a 52 week low of $2.82 and a 52 week high of $7.20. The stock has a 50-day moving average of $4.02 and a 200-day moving average of $4.45. The company’s market cap is $123.3 million.

Fibrocell Science, Inc is an aesthetic and therapeutic development stage biotechnology company focused on developing novel skin and tissue rejuvenation products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.